SAMJIN PHARMACEUTICAL CO.,LTD Logo

SAMJIN PHARMACEUTICAL CO.,LTD

Researches, develops, manufactures, and sells OTC and prescription medicines.

005500 | KO

Overview

Corporate Details

ISIN(s):
KR7005500004
LEI:
Country:
South Korea
Address:
서울특별시 마포구 와우산로 121 삼진제약사옥, 마포구

Description

Samjin Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medicines. The company's portfolio includes a wide range of over-the-counter (OTC) and prescription drugs, offered in various formulations such as oral, drop, and injectable forms. Notable products include the analgesic Gevorin, the antiplatelet agent Plavix, and the hypercholesterolemia treatment Newstatin-R. A central part of its strategy is a strong commitment to R&D, focusing on creating innovative new drugs to address diseases with high unmet medical needs. The company actively develops novel therapeutics for severe conditions, including cardiovascular, respiratory, and gastrointestinal diseases, with the goal of becoming a global pharmaceutical innovator.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
주식등의대량보유상황보고서(일반)
Korean 126.6 KB
2025-08-27 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-08-21 00:00
주식등의대량보유상황보고서(일반)
Korean 126.6 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.1 MB
2025-07-29 00:00
주식등의대량보유상황보고서(일반)
Korean 96.6 KB
2025-07-21 00:00
주식등의대량보유상황보고서(일반)
Korean 96.6 KB
2025-07-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.1 MB
2025-05-12 00:00
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 27.9 KB
2025-05-12 00:00
신탁계약해지결과보고서
Korean 18.4 KB
2025-03-21 00:00
정기주주총회결과
Korean 25.7 KB
2025-03-21 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.2 KB
2025-03-21 00:00
대표이사(대표집행임원)변경(안내공시)
Korean 5.7 KB
2025-03-13 00:00
감사보고서제출
Korean 11.3 KB
2025-03-13 00:00
사업보고서 (2024.12)
Korean 1.4 MB

Automate Your Workflow. Get a real-time feed of all SAMJIN PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SAMJIN PHARMACEUTICAL CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SAMJIN PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.